NON-ALCOHOLIC FATTY LIVER DISEASE: CLINICAL FEATURES, DIAGNOSIS, AND MANAGEMENT STRATEGIES
Article Sidebar
Main Article Content
Abstract
Non-alcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver disorder worldwide, strongly associated with obesity, metabolic syndrome, and type 2 diabetes mellitus. Its progression from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma underscores its clinical and public health importance. This article aims to review the clinical features, diagnostic methods, and management strategies for NAFLD within the context of modern hepatology.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease. Hepatology. 2018;67(1):328–357.
2. EASL–EASD–EASO Clinical Practice Guidelines for the management of NAFLD. J Hepatol. 2016;64(6):1388–1402.
3. Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13(6):328–340.
4. Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–922.
5. Rinella ME. Nonalcoholic fatty liver disease: A systematic review. JAMA. 2015;313(22):2263–2273.